Related Experiment Video
Updated: Dec 22, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.8K
Parkinson's Disease EMG Data Augmentation and Simulation with DCGANs and Style Transfer
Rafael Anicet Zanini1, Esther Luna Colombini1
1Laboratory of Robotics and Cognitive Science (LaRoCS), Universidade Estadual de Campinas (UNICAMP), Campinas SP 13083-852, Brazil.
Sensors (Basel, Switzerland)
|May 8, 2020
Summary
This study introduces novel Deep Convolutional Generative Adversarial Networks (DCGANs) and Style Transfer methods to augment Parkinson's Disease (PD) electromyography (EMG) signals, enhancing tremor simulation for treatment validation.
Area of Science:
- Biomedical Engineering
- Signal Processing
- Machine Learning
Background:
- Parkinson's Disease (PD) diagnosis and treatment monitoring often rely on electromyography (EMG) signals.
- Acquiring diverse and extensive EMG datasets for research and validation is challenging.
- Existing data augmentation techniques may not adequately capture the complexity of PD tremors.
Purpose of the Study:
- To develop advanced data augmentation techniques for Parkinson's Disease (PD) electromyography (EMG) signals.
- To improve the simulation of patient-specific tremor patterns.
- To create a more robust dataset for validating therapeutic interventions.
Main Methods:
- Implementation of Deep Convolutional Generative Adversarial Networks (DCGANs) for EMG signal generation.
- Application of Style Transfer techniques to augment existing EMG data.
- Validation of generated signals against natural tremor characteristics (frequency, amplitude).
Main Results:
- The proposed DCGAN and Style Transfer models effectively augmented PD EMG datasets.
- The models demonstrated adaptability to varying tremor frequencies and amplitudes.
- Simulated tremor patterns accurately reflected individual patient characteristics.
Conclusions:
- The novel data augmentation approaches significantly enhance the available PD EMG datasets.
- These methods provide a powerful tool for generating realistic tremor simulations.
- The generated simulations can be utilized for validating Parkinson's treatment strategies across diverse movement scenarios.
Related Concept Videos
Parkinson's Disease: Treatment
852
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
852
Parkinson's Disease: Overview
1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K

